Drug Target Review Antibodies ebook 2021
Posted: 22 September 2021 | Drug Target Review | No comments yet
This ebook has features on the development of intranasally-delivered antibodies to combat SARS-CoV-2 and how the structure of a nanobody was determined using nuclear magnetic resonance methods.
In this collection of articles, Dr Steve Carroll explains why antibody therapeutics continue to be required in the fight against COVID-19. He also outlines recent research into an Immunoglobulin M (IgM) antibody platform that could combat SARS‑CoV-2 and its variants.
In a Q&A, Professor Gennaro Esposito discusses nanobodies and why this class of small protein, derived from antibodies occurring in camelids and sharks, has the potential to fight a wide range of diseases.
Included in this ebook:
Drug Target Review has just announced the launch of its NEW and EXCLUSIVE report examining the evolution of AI and informatics in drug discovery and development.
In this 63 page in-depth report, experts and researchers explore the key benefits of AI and informatics processes, reveal where the challenges lie for the implementation of AI and how they see the use of these technologies streamlining workflows in the future.
Also featured are exclusive interviews with leading scientists from AstraZeneca, Auransa, PolarisQB and Chalmers University of Technology.
- An IgM antibody platform to tackle SARS‑CoV-2 and its variants
Dr Steve Carroll, IGM Biosciences - Determining the structure of nanobodies using nuclear magnetic resonance spectroscopy
Professor Gennaro Esposito, New York University (NYU) Abu Dhabi
